Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation
Status:
Terminated
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, randomized, double-blind, double-dummy study designed to compare the
effects of risedronate, raloxifene, and placebo on BMD, bone turnover markers, and other
markers of anabolic activity in postmenopausal women who previously received HRT.